logo

Global Blood Therapeutics (GBT)



Trade GBT now with
  Date
  Headline
1/10/2018 8:52:20 AM Orphan Rare Diseases R&D Advancements Increase Novel Therapeutic Options For Drug Development Pipeline
1/9/2018 8:10:20 AM GBT Gets FDA Breakthrough Therapy Designation For Voxelotor For Treatment Of Sickle Cell Disease
12/15/2017 5:06:12 PM Wedbush Is Raising Global Blood Therapeutics (GBT) FY18 Estimate To -2.80 From -2.99
12/15/2017 5:05:50 PM Wedbush Is Raising Global Blood Therapeutics (GBT) Q4 18 Estimate To -0.73 From -0.78
12/15/2017 5:05:28 PM Wedbush Is Increasing Global Blood Therapeutics (GBT) Q3 18 Estimate To -0.71 From -0.76
12/15/2017 5:05:09 PM Wedbush Is Increasing Global Blood Therapeutics (GBT) Q2 18 Estimate To -0.69 From -0.74
12/15/2017 5:04:52 PM Wedbush Is Raising Global Blood Therapeutics (GBT) Q1 18 Estimate To -0.67 From -0.72
12/15/2017 5:04:31 PM Wedbush Is Raising Global Blood Therapeutics (GBT) FY17 Estimate To -2.46 From -2.51
12/15/2017 5:04:13 PM Wedbush Is Increasing Global Blood Therapeutics (GBT) Q4 17 Estimate To -0.65 From -0.69
12/15/2017 5:03:36 PM Wedbush Reiterates Global Blood Therapeutics (GBT) At Outperform With $73 Price Target
12/15/2017 9:07:46 AM Global Blood Therapeutics Prices $100.0 Mln Common Stock Public Offering
12/4/2017 6:14:55 AM Wedbush Reiterates Global Blood Therapeutics (GBT) At Outperform With $73 Price Target